← Leaderboards
Laura Marie Rogers
Mayo Clinic Rochester
$2,344,554
Attributed
$2,344,554
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $457.6K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,344,554 · 3
By mechanism
R37$1,350,024 · 1
K22$557,280 · 1
R21$437,250 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Charles Lee Howe$6,719,913
- Richard G Vile$15,977,609
- Naureen Javeed$3,091,846
- Ukpong Bassey Eyo$5,689,257
- Allan James Bieber$1,049,768
Others in their field
Other Emerging Leaders on “Genetic Screening”
- Leonard Freedman · Leidos Biomedical Research, Inc.$54,619,568
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Lynn Briscoe · Leidos Biomedical Research, Inc.$23,229,499
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
- Badri N Vardarajan · University Of Miami School Of Medicine$14,088,684
Research focus
Genetic ScreeningTumorDesignInnovationAdoptive TransferExperimental StudyT-LymphocyteTherapeutic TargetMediatingOverexpressionTumor MicroenvironmentTreatment StrategyGenesT Cell TherapyChimeric Antigen Receptor T CellsSleeping BeautyMutateMutationCancer ImmunotherapySeriesKnock-OutSuccessGeneticCell Surface
Grant awards (8)
Aak1 to increase infiltration of adoptively transferred cells into solid tumors$457,635
R37 · FY2025 · CA · contact PI
Aak1 to increase infiltration of adoptively transferred cells into solid tumors$434,754
R37 · FY2024 · CA · contact PI
Aak1 to increase infiltration of adoptively transferred cells into solid tumors$457,635
R37 · FY2023 · CA · contact PI
Understanding the impact of AAK1 on T cell chemokine receptor expression and chemotaxis$198,750
R21 · FY2022 · AI · contact PI
Understanding the impact of AAK1 on T cell chemokine receptor expression and chemotaxis$238,500
R21 · FY2021 · AI · contact PI
Rationally improving T cell-mediated immunotherapy using Sleeping Beauty mutagenesis$185,760
K22 · FY2021 · CA · contact PI
Rationally improving T cell-mediated immunotherapy using Sleeping Beauty mutagenesis$185,760
K22 · FY2020 · CA · contact PI
Rationally improving T cell-mediated immunotherapy using Sleeping Beauty mutagenesis$185,760
K22 · FY2019 · CA · contact PI